TLX 0.00% $18.40 telix pharmaceuticals limited

TLX Chart, page-267

  1. 2,120 Posts.
    lightbulb Created with Sketch. 548
    Gentle reminder. EU sales to be approved by end of 2023 but actual sales not to be expected before FY '24 (see below). It's only one of many SP catalysts scheduled until then in 2023 (see below) though.

    https://hotcopper.com.au/data/attachments/5158/5158706-642eaf93518b7cddc6263cb573e128a3.jpg


    27/02/23

    https://hotcopper.com.au/threads/ann-2022-full-year-results-presentation.7253440/page-41?post_id=66527923

    Question
    David Stanton (Analysts)

    One on time lines and then a couple for Darren, if I may. So time lines for the European Illuccix submission, please. When should we expect sales in Europe -- reimbursed sales in Europe for that product, please?

    Answer
    Christian Behrenbruch (Executives)

    So we are getting ready right now. We have a package ready for resubmission. We're just getting ready to submit. The expectation is that we will still do that by the end of this quarter as we previously guided. We will not be able to give clear firm time lines yet on what the approval looks like because it depends a little bit on some nuances of that resubmission process. But obviously, as soon as we have that information to share, we will. We would expect to have at least a positive opinion by the end of the year. So I think this year is really about that resubmission process and '24 is likely to be the revenue consequences of that regulatory process.

 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$18.40
Change
0.000(0.00%)
Mkt cap ! $6.149B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 619 $20.24
 

Sellers (Offers)

Price($) Vol. No.
$17.48 1109 4
View Market Depth
Last trade - 10.02am 28/06/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.